Search

The FDA approved Rebyota, the first fecal microbiota product, for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older. Rebyota is administered rectally as a single dose and is pr

Necrotizing enterocolitis is a currently unpreventable life-threatening GI disorder of preterm infants. Fecal microbiota transplantation is promising, but risks transfer of pathogenic microbes. Anders Brunse (University of Copenhagen, Denma

Lorraine Draper (APC Microbiome Ireland) and colleagues published a new paper in BMC Biology showing the impact of faecal viral transfer (FVT) on the mouse microbiome after antibiotic perturbation. They saw that FVT helped the mice get back